Mast cells in neuroinflammation and brain disorders

Neuroscience and Biobehavioral Reviews

Volumn 79, Issue , 2017, Pages 119-133

  Hendriksen, Erik ^a   van Bergeijk, Doris ^a   Oosting, Ronald S ^a   Redegeld, Frank A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Blood brain barrier; Mast cells; Neurodegeneration; Neurogenesis; Neuroinflammation

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; SEROTONIN; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AUTISM; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL DEATH; DEPRESSION; EXCITOTOXICITY; GLIA CELL; HUMAN; MAST CELL; MIGRAINE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNAPTIC TRANSMISSION; TRAUMATIC BRAIN INJURY; DEGENERATIVE DISEASE; GLIA;

BLOOD-BRAIN BARRIER; HUMANS; MAST CELLS; NEURODEGENERATIVE DISEASES; NEUROGLIA;

EID: 85019889098     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2017.05.001     Document Type: Review

References (241)

1. Acosta, S.A., Tajiri, N., de la Pena, I., Bastawrous, M., Sanberg, P.R., Kaneko, Y., Borlongan, C.V., Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. J. Cell. Physiol. 230:5 (2015), 1024–1032.
2. Ahmad, A., Crupi, R., Impellizzeri, D., Campolo, M., Marino, A., Esposito, E., Cuzzocrea, S., Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. Brain Behav. Immun. 26:8 (2012), 1310–1321.
3. Aich, A., Afrin, L.B., Gupta, K., Mast cell-Mediated mechanisms of nociception. Int. J. Mol. Sci. 16:12 (2015), 29069–29092.
4. Aloisi, F., Immune function of microglia. Glia 36:2 (2001), 165–179.
5. Alysandratos, K.-D., Asadi, S., Angelidou, A., Zhang, B., Sismanopoulos, N., Yang, H., Critchfield, A., Theoharides, T., Neurotensin and CRH interactions augment human mast cell activation. PLoS One, 7(11), 2012, e48934.
6. Ambrée, O., Buschert, J., Zhang, W., Arolt, V., Dere, E., Zlomuzica, A., Impaired spatial learning and reduced adult hippocampal neurogenesis in histamine H1-receptor knockout mice. Eur. Neuropsychopharmacol. 24:8 (2014), 1394–1404.
7. Amor, S., Woodroofe, M.N., Innate and adaptive immune responses in neurodegeneration and repair. Immunology 141:3 (2014), 287–291.
8. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.C., Moskowitz, M.A., Fini, M.E., Lo, E.H., Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21:19 (2001), 7724–7732.
9. Aspelund, A., Antila, S., Proulx, S.T., Karlsen, T.V., Karaman, S., Detmar, M., Wiig, H., Alitalo, K., A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212:7 (2015), 991–999.
10. Bañuelos Cabrera, I., Valle Dorado, M., Aldana, B., Orozco Suárez, S., Rocha, L., Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders. Arch. Med. Res. 45:8 (2014), 677–686.
11. Baba, H., Ji, R.R., Kohno, T., Moore, K.A., Ataka, T., Wakai, A., Okamoto, M., Woolf, C.J., Removal of GABAergic inhibition facilitates polysynaptic A fiber-mediated excitatory transmission to the superficial spinal dorsal horn. Mol. Cell. Neurosci. 24:3 (2003), 818–830.
12. Baranyi, A., Meinitzer, A., Breitenecker, R.J., Amouzadeh-Ghadikolai, O., Stauber, R., Rothenhausler, H.-B., Quinolinic acid responses during interferon-alpha-Induced depressive symptomatology in patients with chronic hepatitis C infection – a novel aspect for depression and inflammatory hypothesis. PLoS One, 10(9), 2015, e0137022.
13. Barone, F.C., Feuerstein, G.Z., Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19:8 (1999), 819–834.
14. Bay-Richter, C., Linderholm, K.R., Lim, C.K., Samuelsson, M., Traskman-Bendz, L., Guillemin, G.J., Erhardt, S., Brundin, L., A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav. Immun. 43 (2015), 110–117.
15. Bennett, J., Blanchet, M.-R., Zhao, L., Zbytnuik, L., Antignano, F., Gold, M., Kubes, P., McNagny, K., Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J. Immunol. 182:9 (2009), 5507–5514.
16. Benros, M.E., Waltoft, B.L., Nordentoft, M., Ostergaard, S.D., Eaton, W.W., Krogh, J., Mortensen, P.B., Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70:8 (2013), 812–820.
17. Bogdanov, V.B., Multon, S., Chauvel, V., Bogdanova, O.V., Prodanov, D., Makarchuk, M.Y., Schoenen, J., Migraine preventive drugs differentially affect cortical spreading depression in rat. Neurobiol. Dis. 41:2 (2011), 430–435.
18. Borsini, A., Zunszain, P.A., Thuret, S., Pariante, C.M., The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 38:3 (2015), 145–157.
19. Bowen, K., Dempsey, R., Vemuganti, R., Adult interleukin-6 knockout mice show compromised neurogenesis. Neuroreport 22:3 (2011), 126–130.
20. Brain, S.D., Williams, T.J., Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmacol. 86:4 (1985), 855–860.
21. Bugajski, A.J., Chlap, Z., Gadek Michalska, J., Effect of isolation stress on brain mast cells and brain histamine levels in rats. Agents Actions 41 (1994), C75–C76 (Spec No).
22. Butler, M.P., O'Connor, J.J., Moynagh, P.N., Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 124:2 (2004), 319–326.
23. Campbell, B.M., Charych, E., Lee, A.W., Moller, T., Kynurenines in CNS disease: regulation by inflammatory cytokines. Front. Neurosci., 8, 2014, 12.
24. Cao, J., Papadopoulou, N., Kempuraj, D., Boucher, W.S., Sugimoto, K., Cetrulo, C.L., Theoharides, T.C., Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J. Immunol. 174:12 (2005), 7665–7675.
25. Carraway, R., Cochrane, D.E., Lansman, J.B., Leeman, S.E., Paterson, B.M., Welch, H.J., Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J. Physiol. (Lond.) 323 (1982), 403–414.
26. Casano Alessandra, M., Peri, F., Microglia: multitasking specialists of the brain. Dev. Cell 32:4 (2015), 469–477.
27. Chatterjea, D., Martinov, T., Mast cells: versatile gatekeepers of pain. Mol. Immunol. 63:1 (2015), 38–44.
28. Chen, Z., Palmer, T.D., Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis. Brain Behav. Immun. 30 (2013), 45–53.
29. Chikahisa, S., Kodama, T., Soya, A., Sagawa, Y., Ishimaru, Y., Sei, H., Nishino, S., Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states. PLoS One, 8(10), 2013, e78434.
30. Choi, S., Howell, O., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P., Nicholas, R., Roncaroli, F., Reynolds, R., Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain 135:10 (2012), 2925–2937.
31. Christy, A.L., Walker, M.E., Hessner, M.J., Brown, M.A., Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J. Autoimmun. 42 (2013), 50–61.
32. Colonna, D.M., Meng, W., Deal, D.D., Busija, D.W., Calcitonin gene-related peptide promotes cerebrovascular dilation during cortical spreading depression in rabbits. Am. J. Physiol. 266:3 (Pt. 2) (1994), H1095–H1102.
33. Corrigan, F., Mander, K.A., Leonard, A.V., Vink, R., Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J. Neuroinflamm., 13(1), 2016, 264.
34. Costanza, M., Colombo, M., Pedotti, R., Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Int. J. Mol. Sci. 13:11 (2012), 15107–15125.
35. Cuadros, M.A., Navascués, J., The origin and differentiation of microglial cells during development. Prog. Neurobiol. 56:2 (1998), 173–189.
36. Cunha, F.Q., Poole, S., Lorenzetti, B.B., Ferreira, S.H., The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107:3 (1992), 660–664.
37. Cunha, T.M., Verri, W.A. Jr., Silva, J.S., Poole, S., Cunha, F.Q., Ferreira, S.H., A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc. Natl. Acad. Sci. U. S. A. 102:5 (2005), 1755–1760.
38. Curran, B.P., Murray, H.J., O'Connor, J.J., A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neuroscience 118:2 (2003), 347–357.
39. da Silva, E.Z.M., Jamur, M., Oliver, C., Mast cell function: a new vision of an old cell. J. Histochem. Cytochem. 62:10 (2014), 698–738.
40. del Rey, A., Balschun, D., Wetzel, W., Randolf, A., Besedovsky, H.O., A cytokine network involving brain-borne IL-1(, IL-1ra, IL-18, IL-6, and TNF(operates during long-term potentiation and learning. Brain Behav. Immun. 33 (2013), 15–23.
41. del Zoppo, G.J., Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Brain − Immune Interact. Acute Chronic Brain Disord. 158:3 (2009), 972–982.
42. Daneman, R., Prat, A., The blood-brain barrier. Cold Spring Harbor Perspect. Biol., 7(1), 2015, a020412.
43. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley KW.;1;: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:1 (2008), 46–56.
44. Davis, M.J., Lane, M.M., Davis, A.M., Durtschi, D., Zawieja, D.C., Muthuchamy, M., Gashev, A.A., Modulation of lymphatic muscle contractility by the neuropeptide substance P. Am. J. Physiol. Heart Circ. Physiol. 295:2 (2008), H587–597.
45. Di Filippo, M., Sarchielli, P., Picconi, B., Calabresi, P., Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol. Sci. 29:8 (2008), 402–412.
46. Di Girolamo, N., Indoh, I., Jackson, N., Wakefield, D., McNeil, H.P., Yan, W., Geczy, C., Arm, J., Tedla, N., Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J. Immunol. 177:4 (2006), 2638–2650.
47. Dietrich, J.-B., The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J. Neuroimmunol. 128:1–2 (2002), 58–68.
48. Dong, H., Zhang, X., Qian, Y., Mast cells and neuroinflammation. Med. Sci. Monit. 20 (2014), 200–206.
49. Dong, H., Zhang, W., Zeng, X., Hu, G., Zhang, H., He, S., Zhang, S., Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol. Neurobiol. 49:3 (2014), 1487–1500.
50. Dong, H., Zhang, X., Wang, Y., Zhou, X., Qian, Y., Zhang, S., Suppression of brain mast cells degranulation inhibits microglial activation and central nervous system inflammation. Mol. Neurobiol., 2016.
51. Dubreuil, P., Letard, S., Ciufolini, M., Gros, L., Humbert, M., Casteran, N., Borge, L., Hajem, B., Lermet, A., Sippl, W., et al. Masitinib (A), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS One, 4(9), 2009, e7258.
52. Duman, R.S., Monteggia, L.M., A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59:12 (2006), 1116–1127.
53. Dworkin, R.H., O'Connor, A.B., Audette, J., Baron, R., Gourlay, G.K., Haanpaa, M.L., Kent, J.L., Krane, E.J., Lebel, A.A., Levy, R.M., et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin. Proc. 85:Suppl. 3 (2010), S3–14.
54. Eiriz, M., Valero, J., Malva, J., Bernardino, L., New insights into the role of histamine in subventricular zone-olfactory bulb neurogenesis. Front. Neurosci., 8, 2014, 142.
55. Eisenberger, N.I., Berkman, E.T., Inagaki, T.K., Rameson, L.T., Mashal, N.M., Irwin, M.R., Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry 68:8 (2010), 748–754.
56. Erhardt, S., Lim, C.K., Linderholm, K.R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T.T., Traskman-Bendz, L., Guillemin, G.J., Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38:5 (2013), 743–752.
57. Esposito, E., Paterniti, I., Mazzon, E., Genovese, T., Di Paola, R., Galuppo, M., Cuzzocrea, S., Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav. Immun. 25:6 (2011), 1099–1112.
58. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S.D., Leon, A., Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U. S. A. 92:8 (1995), 3376–3380.
59. Fang, Q., Hu, W.-W., Wang, X.-F., Yang, Y., Lou, G.-D., Jin, M.-M., Yan, H.-J., Zeng, W.-Z., Shen, Y., Zhang, S.-H., Histamine up-regulates astrocytic glutamate transporter 1 and protects neurons against ischemic injury. Neuropharmacology 77 (2014), 156–166.
60. Felling, R., Levison, S., Enhanced neurogenesis following stroke. J. Neurosci. Res. 73:3 (2003), 277–283.
61. Ferreira, R., Santos, T., Gonçalves, J., Baltazar, G., Ferreira, L., Agasse, F., Bernardino, L., Histamine modulates microglia function. J. Neuroinflamm., 9, 2012, 90.
62. Feuser, K., Thon, K.-P., Bischoff, S., Lorentz, A., Human intestinal mast cells are a potent source of multiple chemokines. Cytokine 58:2 (2012), 178–185.
63. Feyerabend Thorsten, B., Weiser, A., Tietz, A., Stassen, M., Harris, N., Kopf, M., Radermacher, P., Möller, P., Benoist, C., Mathis, D., Cre-mediated cell ablation contests mast cell contribution in models of antibody- and t cell-mediated autoimmunity. Immunity 35:5 (2011), 832–844.
64. Fogal, B., Hewett, S., Interleukin-1beta: a bridge between inflammation and excitotoxicity?. J. Neurochem. 106:1 (2008), 1–23.
65. Frank, B.T., Rossall, J.C., Caughey, G.H., Fang, K.C., Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. J. Immunol. 166:4 (2001), 2783–2792.
66. Furuno, T., Hagiyama, M., Sekimura, M., Okamoto, K., Suzuki, R., Ito, A., Hirashima, N., Nakanishi, M., Cell adhesion molecule 1 (CADM1) on mast cells promotes interaction with dorsal root ganglion neurites by heterophilic binding to nectin-3. J. Neuroimmunol. 250:1–2 (2012), 50–58.
67. Fuster Matanzo, A., Llorens Martín, M., Hernández, F., Avila, J., Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches. Mediators Inflamm., 2013, 2013, 260925.
68. Gabbay, V., Ely, B.A., Babb, J., Liebes, L., The possible role of the kynurenine pathway in anhedonia in adolescents. J. Neural Transm. (Vienna) 119:2 (2012), 253–260.
69. Gadani, S., Walsh, J., Smirnov, I., Zheng, J., Kipnis, J., The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 85:4 (2015), 703–709.
70. Galli, S., Nakae, S., Tsai, M., Mast cells in the development of adaptive immune responses. Nat. Immunol. 6:2 (2005), 135–142.
71. Georgin-Lavialle, S., Moura, D.S., Salvador, A., Chauvet-Gelinier, J.C., Launay, J.M., Damaj, G., Cote, F., Soucie, E., Chandesris, M.O., Barete, S., et al. Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis. Mol. Psychiatry, 2016.
72. Goadsby, P.J., Edvinsson, L., The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33:1 (1993), 48–56.
73. Goadsby, P.J., Lipton, R.B., Ferrari, M.D., Migraine–current understanding and treatment. N. Engl. J. Med. 346:4 (2002), 257–270.
74. Greve, M.W., Zink, B.J., Pathophysiology of traumatic brain injury. Mount Sinai J. Med. (N. Y.) 76:2 (2009), 97–104.
75. Guan, Z., Fang, J., Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav. Immun. 20:1 (2006), 64–71.
76. Hösli, L., Hösli, E., Schneider, U., Wiget, W., Evidence for the existence of histamine H1- and H2-receptors on astrocytes of cultured rat central nervous system. Neurosci. Lett. 48:3 (1984), 287–291.
77. Hagiyama, M., Furuno, T., Hosokawa, Y., Iino, T., Ito, T., Inoue, T., Nakanishi, M., Murakami, Y., Ito, A., Enhanced nerve-mast cell interaction by a neuronal short isoform of cell adhesion molecule-1. J. Immunol. 186:10 (2011), 5983–5992.
78. Harcha, P., Vargas, A., Yi, C., Koulakoff, A., Giaume, C., Sáez, J., Hemichannels are required for amyloid ß-Peptide-Induced degranulation and are activated in brain mast cells of APPswe/PS1dE9 mice. J. Neurosci. 35:25 (2015), 9526–9538.
79. Hauser, W., Janke, K.H., Klump, B., Hinz, A., Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm. Bowel Dis. 17:2 (2011), 621–632.
80. Heldmann, U., Thored, P., Claasen, J.-H., Arvidsson, A., Kokaia, Z., Lindvall, O., TNF-alpha antibody infusion impairs survival of stroke-generated neuroblasts in adult rat brain. Exp. Neurol. 196:1 (2005), 204–208.
81. Hendrix, S., Kramer, P., Pehl, D., Warnke, K., Boato, F., Nelissen, S., Lemmens, E., Pejler, G., Metz, M., Siebenhaar, F., Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4. FASEB J. 27:3 (2013), 920–929.
82. Hermine, O., Lortholary, O., Leventhal, P.S., Catteau, A., Soppelsa, F., Baude, C., Cohen-Akenine, A., Palmerini, F., Hanssens, K., Yang, Y., et al. Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One, 3(5), 2008, e2266.
83. Hilmas, C., Pereira, E.F., Alkondon, M., Rassoulpour, A., Schwarcz, R., Albuquerque, E.X., The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21:19 (2001), 7463–7473.
84. Hoyo-Becerra, C., Schlaak, J.F., Hermann, D.M., Insights from interferon-alpha-related depression for the pathogenesis of depression associated with inflammation. Brain Behav. Immun. 42 (2014), 222–231.
85. Hu, W., Fan, Y., Shen, Y., Yang, Y., Dai, H., Fu, Q., Chen, Z., Mast cell-derived mediators protect against oxygen–glucose deprivation-induced injury in PC12 cells and neurons. Neurosci. Lett. 423:1 (2007), 35–40.
86. Hu, X., Liou, A.K.F., Leak, R.K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., Chen, J., Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog. Neurobiol. 119:120 (2014), 60–84.
87. Hu, W.-W., Chen, Z., Role of histamine and its receptors in cerebral ischemia. ACS Chem. Neurosci. 3:4 (2012), 238–247.
88. Ibrahim, M.Z.M., Reder, A.T., Lawand, R., Takash, W., Sallouh-Khatib, S., The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70:2 (1996), 131–138.
89. Iikura, M., Suto, H., Kajiwara, N., Oboki, K., Ohno, T., Okayama, Y., Saito, H., Galli, S., Nakae, S., IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87:10 (2007), 971–978.
90. Isik, A., Koca, S.S., Ozturk, A., Mermi, O., Anxiety and depression in patients with rheumatoid arthritis. Clin. Rheumatol. 26:6 (2007), 872–878.
91. Jensen, T.S., Baron, R., Haanpaa, M., Kalso, E., Loeser, J.D., Rice, A.S., Treede, R.D., A new definition of neuropathic pain. Pain 152:10 (2011), 2204–2205.
92. Jensen, C., Massie, A., De Keyser, J., Immune players in the CNS: the astrocyte. J. Neuroimmune Pharmacol. 8:4 (2013), 824–839.
93. Jin, Y., Silverman, A., Vannucci, S., Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 40:9 (2009), 3107–3112.
94. Kallweit, U., Aritake, K., Bassetti, C., Blumenthal, S., Hayaishi, O., Linnebank, M., Baumann, C., Urade, Y., Elevated CSF histamine levels in multiple sclerosis patients. Fluids Barriers CNS, 10, 2013, 19.
95. Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., Aubry, J.M., Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109:2 (2002), 143–148.
96. Karimi, K., Kool, M., Nijkamp, F.P., Redegeld, F.A., Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells. Eur. J. Pharmacol. 489:1–2 (2004), 49–54.
97. Kawasaki, H., Chang, H.W., Tseng, H.C., Hsu, S.C., Yang, S.J., Hung, C.H., Zhou, Y., Huang, S.K., A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor. Allergy 69:4 (2014), 445–452.
98. Keaney, J., Campbell, M., The dynamic blood-brain barrier. FEBS J. 282:21 (2015), 4067–4079.
99. Kenis, G., Prickaerts, J., van Os, J., Koek, G.H., Robaeys, G., Steinbusch, H.W., Wichers, M., Depressive symptoms following interferon-alpha therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?. Int. J. Neuropsychopharmacol. 14:2 (2011), 247–253.
100. Keohane, A., Ryan, S., Maloney, E., Sullivan, A.M., Nolan, Y.M., Tumour necrosis factor-α impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: role of Hes1. Mol. Cell. Neurosci. 43:1 (2010), 127–135.
101. Kim, H.Y., Park, C.K., Cho, I.H., Jung, S.J., Kim, J.S., Oh, S.B., Differential Changes in TRPV1 expression after trigeminal sensory nerve injury. J. Pain 9:3 (2008), 280–288.
102. Kim, D., Jeoung, D., Ro, J., Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J. Immunol. 185:1 (2010), 273–283.
103. Kim, D., Hong, G., Ro, J., Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J. Neuroinflamm., 8(1), 2011, 25.
104. Kitamura, Y., Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol., 1989, 59–76.
105. Kocic, I., Kowianski, P., Rusiecka, I., Lietzau, G., Mansfield, C., Moussy, A., Hermine, O., Dubreuil, P., Neuroprotective effect of masitinib in rats with postischemic stroke. Naunyn-Schmiedeberg's Arch. Pharmacol. 388:1 (2015), 79–86.
106. Koo, J., Duman, R., IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. U. S. A. 105:2 (2008), 751–756.
107. Kulka, M., Sheen, C., Tancowny, B., Grammer, L., Schleimer, R., Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123:3 (2008), 398–410.
108. Kumar, A., Loane, D.J., Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav. Immun. 26:8 (2012), 1191–1201.
109. Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., Bechmann, I., Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 19:10 (2005), 1347–1349.
110. Lee Mosley, R., Adaptive immunity in neurodegenerative and neuropsychological disorders. J. Neuroimmune Pharmacol. 10:4 (2015), 522–527.
111. Lehnardt, S., Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58:3 (2010), 253–263.
112. Levy, D., Migraine pain, meningeal inflammation, and mast cells. Curr. Pain Headache Rep. 13:3 (2009), 237–240.
113. Li, X., Chauhan, A., Sheikh, A.M., Patil, S., Chauhan, V., Li, X.-M., Ji, L., Brown, T., Malik, M., Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 207:1–2 (2009), 111–116.
114. Li, H., Nourbakhsh, B., Safavi, F., Li, K., Xu, H., Cullimore, M., Zhou, F., Zhang, G., Rostami, A., Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J. Immunol. 187:1 (2011), 274–282.
115. Lindsberg, P., Strbian, D., Karjalainen Lindsberg, M.-L., Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J. Cereb. Blood Flow Metab. 30:4 (2010), 689–702.
116. Lipton, R.B., Bigal, M.E., Diamond, M., Freitag, F., Reed, M.L., Stewart, W.F., Group, A.A., Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:5 (2007), 343–349.
117. Liu, H., Luiten, P.G.M., Eisel, U.L.M., Dejongste, M.J.L., Schoemaker, R.G., Depression after myocardial infarction: TNF-α-induced alterations of the blood–brain barrier and its putative therapeutic implications. Neurosci. Biobehav. Rev. 37:4 (2013), 561–572.
118. Loane, D.J., Kumar, A., Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp. Neurol. 275:Pt. 3 (2016), 316–327.
119. Louveau, A., Smirnov, I., Keyes, T.J., Eccles, J.D., Rouhani, S.J., Peske, J.D., Derecki, N.C., Castle, D., Mandell, J.W., Lee, K.S., Structural and functional features of central nervous system lymphatic vessels. Nature 523:7560 (2015), 337–341.
120. Lozada, A., Maegele, M., Stark, H., Neugebauer, E.M., Panula, P., Traumatic brain injury results in mast cell increase and changes in regulation of central histamine receptors. Neuropathol. Appl. Neurobiol. 31:2 (2005), 150–162.
121. Lozano, D., Gonzales-Portillo, G.S., Acosta, S., de la Pena, I., Tajiri, N., Kaneko, Y., Borlongan, C.V., Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatric Dis. Treat. 11 (2015), 97–106.
122. Lu, C., Diehl, S., Noubade, R., Ledoux, J., Nelson, M., Spach, K., Zachary, J., Blankenhorn, E., Teuscher, C., Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 107:44 (2010), 18967–18972.
123. Lyman, M., Lloyd, D., Ji, X., Vizcaychipi, M., Ma D: Neuroinflammation: the role and consequences. Neurosci. Res. 79 (2014), 1–12.
124. Maas, A.I., Stocchetti, N., Bullock, R., Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7:8 (2008), 728–741.
125. Madry, C., Attwell, D., Receptors, ion channels, and signaling mechanisms underlying microglial dynamics. J. Biol. Chem. 290:20 (2015), 12443–12450.
126. Maes, M., Leonard, B.E., Myint, A.M., Kubera, M., Verkerk, R., The new ‘5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35:3 (2011), 702–721.
127. Maslinska, D., Laure Kamionowska, M., Gujski, M., Ciurzynska, G., Wojtecka Lukasik, E., Post-infectional distribution and phenotype of mast cells penetrating human brains. Inflamm. Res. 54:Suppl. 1 (2005), S15–16.
128. Maslinska, D., Laure Kamionowska, M., Maslinski, K.T., Gujski, M., Maslinski, S., Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits. Inflamm. Res. 56:Suppl. 1 (2007), S17–18.
129. Mattila, O., Strbian, D., Saksi, J., Pikkarainen, T., Rantanen, V., Tatlisumak, T., Lindsberg, P., Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke 42:12 (2011), 3600–3605.
130. McKittrick, C., Lawrence, C., Carswell, H.V.O., Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 35:4 (2015), 638–647.
131. Mele, T., Juric, D., Identification and pharmacological characterization of the histamine H3 receptor in cultured rat astrocytes. Eur. J. Pharmacol. 720:1–3 (2013), 198–204.
132. Mittelbronn, M., Dietz, K., Schluesener, H.J., Meyermann, R., Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol. (Berl.) 101:3 (2001), 249–255.
133. Molina Hernández, A., Velasco, I., Histamine induces neural stem cell proliferation and neuronal differentiation by activation of distinct histamine receptors. J. Neurochem. 106:2 (2008), 706–717.
134. Monje, M.L., Toda, H., Palmer, T.D., Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:5651 (2003), 1760–1765.
135. Montgomery, S., Bowers, W., Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol. 7:1 (2012), 42–59.
136. Moretti, R., Chhor, V., Bettati, D., Banino, E., De Lucia, S., Le Charpentier, T., Lebon, S., Schwendimann, L., Pansiot, J., Rasika, S., Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury. J. Neurosci. Res. 94:12 (2016), 1546–1560.
137. Mossner, R., Lesch, K.P., Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12:4 (1998), 249–271.
138. Moulin, D., Donzé, O., Talabot-Ayer, D., Mézin, F., Palmer, G., Gabay, C., Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40:3 (2007), 216–225.
139. Moura, D.S., Sultan, S., Georgin-Lavialle, S., Pillet, N., Montestruc, F., Gineste, P., Barete, S., Damaj, G., Moussy, A., Lortholary, O., et al. Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy. PLoS One, 6(10), 2011, e26375.
140. Murphy, S.F., Schaeffer, A.J., Done, J., Wong, L., Bell-Cohn, A., Roman, K., Cashy, J., Ohlhausen, M., Thumbikat, P., IL17 mediates pelvic pain in experimental autoimmune prostatitis (EAP). PLoS One, 10(5), 2015, e0125623.
141. Nakanishi, M., Niidome, T., Matsuda, S., Akaike, A., Kihara, T., Sugimoto, H., Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur. J. Neurosci. 25:3 (2007), 649–658.
142. Nautiyal, K., Liu, C., Dong, X., Silver, R., Blood-borne donor mast cell precursors migrate to mast cell-rich brain regions in the adult mouse. J. Neuroimmunol. 240:241 (2011), 142–146.
143. Nautiyal, K., Dailey, C., Jahn, J., Rodriquez, E., Son, N., Sweedler, J., Silver, R., Serotonin of mast cell origin contributes to hippocampal function. Eur. J. Neurosci. 36:3 (2012), 2347–2359.
144. Nautiyal, K.M., Dailey, C.A., Jahn, J.L., Rodriquez, E., Son, N.H., Sweedler, J.V., Silver, R., Serotonin of mast cell origin contributes to hippocampal function. Eur. J. Neurosci. 36:3 (2012), 2347–2359.
145. Nelissen, S., Lemmens, E., Geurts, N., Kramer, P., Maurer, M., Hendriks, J., Hendrix, S., The role of mast cells in neuroinflammation. Acta Neuropathol. (Berl.) 125:5 (2013), 637–650.
146. Nelson, T.E., Olde Engberink, A., Hernandez, R., Puro, A., Huitron-Resendiz, S., Hao, C., De Graan, P.N.E., Gruol, D.L., Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6. Brain Behav. Immun. 26:6 (2012), 959–971.
147. Noordenbos, T., Yeremenko, N., Gofita, I., van de Sande, M., Tak, P.P., Canete, J.D., Baeten, D., Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 64:1 (2012), 99–109.
148. O'Connor, J.C., Andre, C., Wang, Y., Lawson, M.A., Szegedi, S.S., Lestage, J., Castanon, N., Kelley, K.W., Dantzer, R., Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J. Neurosci. 29:13 (2009), 4200–4209.
149. Okie, S., Traumatic brain injury in the war zone. N. Engl. J. Med. 352:20 (2005), 2043–2047.
150. Olmos, G., Lladó, J., Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm., 2014, 2014, 861231.
151. Paladini, A., Fusco, M., Cenacchi, T., Schievano, C., Piroli, A., Varrassi, G., Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Phys. 19:2 (2016), 11–24.
152. Patas, K., Penninx, B.W., Bus, B.A., Vogelzangs, N., Molendijk, M.L., Elzinga, B.M., Bosker, F.J., Oude Voshaar, R.C., Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features. Brain Behav. Immun. 36 (2014), 71–79.
153. Patel, A., Vasanthan, V., Fu, W., Fahlman, R., MacTavish, D., Jhamandas, J., Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype. Brain Struct. Funct., 2015, 1–16.
154. Pickering, M., Cumiskey, D., O'Connor, J., Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp. Physiol. 90:5 (2005), 663–670.
155. Piconese, S., Costanza, M., Musio, S., Tripodo, C., Poliani, P., Gri, G., Burocchi, A., Pittoni, P., Gorzanelli, A., Colombo, M., Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice. Lab. Invest. 91:4 (2011), 627–641.
156. Pietrobon, D., Moskowitz, M.A., Pathophysiology of migraine. Annu. Rev. Physiol. 75 (2013), 365–391.
157. Pietrobon, D., Striessnig, J., Neurobiology of migraine. Nat. Rev. Neurosci. 4:5 (2003), 386–398.
158. Pietrzak, A., Wierzbicki, M., Wiktorska, M., Brzezinska Blaszczyk, E., Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm., 2011, 2011, 427473.
159. Piette, F., Belmin, J., Vincent, H., Schmidt, N., Pariel, S., Verny, M., Marquis, C., Mely, J., Hugonot Diener, L., Kinet, J.-P., et al. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial. Alzheimer's Res. Ther., 3(2), 2011, 16.
160. Pinho-Ribeiro, F.A., Verri, W.A. Jr., Chiu, I.M., Nociceptor sensory neuron-Immune interactions in pain and inflammation. Trends Immunol. 38:1 (2017), 5–19.
161. Polyzoidis, S., Koletsa, T., Panagiotidou, S., Ashkan, K., Theoharides, T., Mast cells in meningiomas and brain inflammation. J. Neuroinflamm., 12(1), 2015, 170.
162. Raison, C.L., Dantzer, R., Kelley, K.W., Lawson, M.A., Woolwine, B.J., Vogt, G., Spivey, J.R., Saito, K., Miller, A.H., CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 15:4 (2010), 393–403.
163. Ribatti, D., The crucial role of mast cells in blood-brain barrier alterations. Exp. Cell Res. 338:1 (2015), 119–125.
164. Rochfort, K.D., Cummins, P.M., Cytokine-mediated dysregulation of zonula occludens-1 properties in human brain microvascular endothelium. Microvasc. Res. 100 (2015), 48–53.
165. Rochfort, K., Collins, L., Murphy, R., Cummins, P., Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One, 9(7), 2014, e101815.
166. Rochfort, K., Collins, L., McLoughlin, A., Cummins, P., TNF-a-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory IL-6. J. Neurochem., 2015.
167. Rodrigues, M.C.O., Sanberg, P., Cruz, L., Garbuzova Davis, S., The innate and adaptive immunological aspects in neurodegenerative diseases. J. Neuroimmunol. 269:1–2 (2014), 1–8.
168. Rogers, M.P., Bloomingdale, K., Murawski, B.J., Soter, N.A., Reich, P., Austen, K.F., Mixed organic brain syndrome as a manifestation of systemic mastocytosis. Psychosom. Med. 48:6 (1986), 437–447.
169. Rosell, A., Cuadrado, E., Ortega Aznar, A., Hernández Guillamon, M., Lo, E., Montaner, J., MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39:4 (2008), 1121–1126.
170. Russi, A., Brown, M., The meninges: new therapeutic targets for multiple sclerosis. Transl. Res. 165:2 (2015), 255–269.
171. Salter Michael, W., Beggs, S., Sublime microglia: expanding roles for the guardians of the CNS. Cell 158:1 (2014), 15–24.
172. Saluja, R., Khan, M., Church, M., Maurer, M., The role of IL-33 and mast cells in allergy and inflammation. Clin. Transl. Allergy, 5, 2015, 33.
173. Sarchielli, P., Alberti, A., Baldi, A., Coppola, F., Rossi, C., Pierguidi, L., Floridi, A., Calabresi, P., Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46:2 (2006), 200–207.
174. Savitz, J., Role of kynurenine metabolism pathway activation in major depressive disorders. Curr. Top. Behav. Neurosci., 2016.
175. Sayed, B.A., Christy, A.L., Walker, M.E., Brown, M.A., Meningeal mast cells affect early t cell central nervous system infiltration and blood-Brain barrier integrity through TNF: a role for neutrophil recruitment?. J. Immunol. 184:12 (2010), 6891–6900.
176. Secor, V.H., Secor, W.E., Gutekunst, C.A., Brown, M.A., Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191:5 (2000), 813–822.
177. Shimada, R., Nakao, K., Furutani, R., Kibayashi, K., A rat model of changes in dural mast cells and brain histamine receptor H3 expression following traumatic brain injury. J. Clin. Neurosci. 19:3 (2012), 447–451.
178. Sibilano, R., Frossi, B., Calvaruso, M., Danelli, L., Betto, E., Dall'Agnese, A., Tripodo, C., Colombo, M.P., Pucillo, C.E., Gri, G., The aryl hydrocarbon receptor modulates acute and late mast cell responses. J. Immunol. 189:1 (2012), 120–127.
179. Silver, R., Curley, J., Mast cells on the mind: new insights and opportunities. Trends Neurosci. 36:9 (2013), 513–521.
180. Silver, R., Silverman, A.-J., Vitković, L., Lederhendler, I.I., Mast cells in the brain: evidence and functional significance. Trends Neurosci. 19:1 (1996), 25–31.
181. Silverman, A.J., Sutherland, A.K., Wilhelm, M., Silver, R., Mast cells migrate from blood to brain. J. Neurosci. 20:1 (2000), 401–408.
182. Singh, L.K., Boucher, W., Pang, X., Letourneau, R., Seretakis, D., Green, M., Theoharides TC: Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J. Pharmacol. Exp. Ther. 288:3 (1999), 1349–1356.
183. Sivilotti, L., Woolf, C.J., The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J. Neurophysiol. 72:1 (1994), 169–179.
184. Skaper, S.D., Facci, L., Romanello, S., Leon, A., Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J. Neurochem. 66:3 (1996), 1157–1166.
185. Skaper, S.D., Facci, L., Kee, W.J., Strijbos, P.J., Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells. J. Neurochem. 76:1 (2001), 47–55.
186. Skaper, S., Giusti, P., Facci, L., Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. 26:8 (2012), 3103–3117.
187. Skaper, S., Facci, L., Giusti, P., Mast cells, glia and neuroinflammation: partners in crime?. Immunology 141:3 (2014), 314–327.
188. Skaper, S.D., Facci, L., Giusti, P., Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol. Disord. Drug Targets 13:10 (2014), 1654–1666.
189. Skaper, S.D., Mast cell − glia dialogue in chronic pain and neuropathic pain: blood-Brain barrier implications. CNS Neurol. Disord. Drug Targets 15:9 (2016), 1072–1078.
190. Skuljec, J., Sun, H., Pul, R., Bénardais, K., Ragancokova, D., Moharregh Khiabani, D., Kotsiari, A., Trebst, C., Stangel, M., CCL5 induces a pro-inflammatory profile in microglia in vitro. Cell. Immunol. 270:2 (2011), 164–171.
191. Smith, S.M., Vale, W.W., The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 8:4 (2006), 383–395.
192. Sofroniew, M., Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. The Neuroscientist 20:2 (2014), 160–172.
193. Stokely, M.E., Orr, E.L., Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice. J. Neurotrauma 25:1 (2008), 52–61.
194. Stone, T.W., Darlington, L.G., Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug Discov. 1:8 (2002), 609–620.
195. Stone, T.W., Perkins, M.N., Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol. 72:4 (1981), 411–412.
196. Strbian, D., Karjalainen Lindsberg, M.-L., Tatlisumak, T., Lindsberg, P., Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J. Cereb. Blood Flow Metab. 26:5 (2006), 605–612.
197. Strbian, D., Kovanen, P., Karjalainen Lindsberg, M.-L., Tatlisumak, T., Lindsberg, P., An emerging role of mast cells in cerebral ischemia and hemorrhage. Ann. Med. (Helsinki) 41:6 (2009), 438–450.
198. Tang, C., Xue, H.-L., Bai, C.-L., Fu, R., Regulation of adhesion molecules expression in TNF-α-stimulated brain microvascular endothelial cells by tanshinone IIA: involvement of NF-κB and ROS generation. PTR Phytother. Res. 25:3 (2011), 376–380.
199. Tchougounova, E., Lundequist, A., Fajardo, I., Winberg, J.-O., Abrink, M., Pejler, G., A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280:10 (2005), 9291–9296.
200. Theoharides, T.C., Cochrane, D.E., Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146:1–2 (2004), 1–12.
201. Theoharides, T.C., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J.J., Webster, E., Chrousos, G.P., Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology 136:12 (1995), 5745–5750.
202. Theoharides, T., Asadi, S., Panagiotidou, S., Weng, Z., The missing link in autoimmunity and autism: extracellular mitochondrial components secreted from activated live mast cells. Autoimmun. Rev. 12:12 (2013), 1136–1142.
203. Theoharides, T.C., Stewart, J.M., Panagiotidou, S., Melamed, I., Mast cells, brain inflammation and autism. Eur. J. Pharmacol. 778 (2016), 96–102.
204. Tietjen, G.E., Migraine as a systemic disorder. Neurology 68:19 (2007), 1555–1556.
205. Toms, R., Weiner, H.L., Johnson, D., Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30:2 (1990), 169–177.
206. Tsao, C.W., Lin, Y.S., Cheng, J.T., Lin, C.F., Wu, H.T., Wu, S.R., Tsai, W.H., Interferon-alpha-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter. J. Psychopharmacol. 22:7 (2008), 753–760.
207. Tsilioni, I., Dodman, N., Petra, A.I., Taliou, A., Francis, K., Moon Fanelli, A., Shuster, L., Theoharides, T.C., Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. Transl. Psychiatry, 4, 2014, e466.
208. Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:9504 (2006), 29–35.
209. Uguz, F., Akman, C., Kucuksarac, S., Tufekci, O., Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin. Neurosci. 63:1 (2009), 50–55.
210. van Heesch, F., Prins, J., Konsman, J.P., Korte-Bouws, G.A., Westphal, K.G., Rybka, J., Olivier, B., Kraneveld, A.D., Korte, S.M., Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice. Eur. J. Pharmacol. 725 (2014), 55–63.
211. van der Kleij, H.P.M., Ma, D., Redegeld, F.A.M., Kraneveld, A., Nijkamp, F., Bienenstock, J., Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J. Immunol. 171:4 (2003), 2074–2079.
212. von Hehn, C.A., Baron, R., Woolf, C.J., Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 73:4 (2012), 638–652.
213. Vallières, L., Campbell, I., Gage, F., Sawchenko, P., Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci. 22:2 (2002), 486–492.
214. Vargas, D., Nascimbene, C., Krishnan, C., Zimmerman, A., Pardo, C., Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57:1 (2005), 67–81.
215. Viviani, B., Boraso, M., Marchetti, N., Marinovich, M., Perspectives on neuroinflammation and excitotoxicity: a neurotoxic conspiracy?. Neurodevelopmental basis of health and disease, The 14th Meeting of the International Neurotoxicology Association 43 (2014), 10–20.
216. Waeber, C., Moskowitz, M.A., Migraine as an inflammatory disorder. Neurology 64:10 (Suppl. 2) (2005), S9–S15.
217. Wang, B., Jin, K., Current perspectives on the link between neuroinflammation and neurogenesis. Metab. Brain Dis. 30:2 (2015), 355–365.
218. Wang, F.-W., Hao, H.-B., Zhao, S.-D., Zhang, Y.-M., Liu, Q., Liu, H.-J., Liu, S.-M., Yuan, Q.-H., Bing, L.-J., Ling, E.-A., et al. Roles of activated astrocyte in neural stem cell proliferation and differentiation. Stem Cell Res. 7:1 (2011), 41–53.
219. Waxweiler, R.J., Thurman, D., Sniezek, J., Sosin, D., O'Neil, J., Monitoring the impact of traumatic brain injury: a review and update. J. Neurotrauma 12:4 (1995), 509–516.
220. Werner, C., Engelhard, K., Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99:1 (2007), 4–9.
221. Wernersson, S., Pejler, G., Mast cell secretory granules: armed for battle. Nat. ReviewsImmunol. 14:7 (2014), 478–494.
222. Wilhelm, M., Silver, R., Silverman, A.J., Central nervous system neurons acquire mast cell products via transgranulation. Eur. J. Neurosci. 22:9 (2005), 2238–2248.
223. Woolf, C.J., Allchorne, A., Safieh-Garabedian, B., Poole, S., Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol. 121:3 (1997), 417–424.
224. Wu, M.D., Montgomery, S.L., Rivera-Escalera, F., Olschowka, J.A., O'Banion, M.K., Sustained IL-1(expression impairs adult hippocampal neurogenesis independent of IL-1 signaling in nestin+ neural precursor cells. Brain Behav. Immun. 32 (2013), 9–18.
225. Xanthos, D., Sandkühler, J., Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat. Rev. Neurosci. 15:1 (2014), 43–53.
226. Yang, Y., Estrada, E., Thompson, J., Liu, W., Rosenberg, G., Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27:4 (2007), 697–709.
227. Yasuoka, S., Kawanokuchi, J., Parajuli, B., Jin, S., Doi, Y., Noda, M., Sonobe, Y., Takeuchi, H., Mizuno, T., Suzumura, A., Production and functions of IL-33 in the central nervous system. Brain Res. 1385 (2011), 8–17.
228. Yowtak, J., Lee, K.Y., Kim, H.Y., Wang, J., Kim, H.K., Chung, K., Chung, J.M., Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain 152:4 (2011), 844–852.
229. Yu, Y., Blokhuis, B., Garssen, J., Redegeld, F., Non-IgE mediated mast cell activation. Eur. J. Pharmacol. S0014-2999:15 (2015), 30144–30148.
230. Yuan, H., Zhu, X., Zhou, S., Chen, Q., Ma, X., He, X., Tian, M., Shi, X., Role of mast cell activation in inducing microglial cells to release neurotrophin. J. Neurosci. Res. 88:6 (2010), 1348–1354.
231. Zhang, H., Lin, L., Yang, H., Zhang, Z., Yang, X., Zhang, L., He, S., Induction of IL-13 production and upregulation of gene expression of protease activated receptors in P815 cells by IL-6. Cytokine 50:2 (2010), 138–145.
232. Zhang, H., Nei, H., Dougherty, P.M., A p38 mitogen-activated protein kinase-dependent mechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-alpha. J. Neurosci. 30:38 (2010), 12844–12855.
233. Zhang, H., Yang, H., He, S., TNF increases expression of IL-4 and PARs in mast cells. Cell. Physiol. Biochem. 26:3 (2010), 327–336.
234. Zhang, B., Angelidou, A., Alysandratos, K.-D., Vasiadi, M., Francis, K., Asadi, S., Theoharides, A., Sideri, K., Lykouras, L., Kalogeromitros, D., Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children. J. Neuroinflamm., 7, 2010, 80.
235. Zhang, S., Zeng, X., Yang, H., Hu, G., He, S., Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell. Physiol. Biochem. 29:5–6 (2012), 931–940.
236. Zhang, B., Asadi, S., Weng, Z., Sismanopoulos, N., Theoharides, T., Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One, 7(12), 2012, e49767.
237. Zhang, S., Dong, H., Zhang, X., Li, N., Sun, J., Qian, Y., Cerebral mast cells contribute to postoperative cognitive dysfunction by promoting blood brain barrier disruption. Behav. Brain Res. 298 (2016), 158–166.
238. Zhu, C.B., Blakely, R.D., Hewlett, W.A., The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:10 (2006), 2121–2131.
239. Zhu, W., Zheng, H., Shao, X., Wang, W., Yao, Q., Li, Z., Excitotoxicity of TNFalpha derived from KA activated microglia on hippocampal neurons in vitro and in vivo. J. Neurochem. 114:2 (2010), 386–396.
240. Zhu, C.B., Lindler, K.M., Owens, A.W., Daws, L.C., Blakely, R.D., Hewlett, W.A., Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35:13 (2010), 2510–2520.
241. Zou, J.Y., Crews, F.T., TNF(potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF(B inhibition. Brain Res. 1034:1–2 (2005), 11–24.